We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current APLMW market cap is 5.59M. The company's latest EPS is USD -0.5993 and P/E is -0.35.
Quarter End | |
---|---|
USD ($) | |
Total Revenue | |
Operating Income | |
Net Income |
Year End December 30 2022 | 2022 |
---|---|
USD ($) | |
Total Revenue | 1.45M |
Operating Income | -233.6M |
Net Income | -240.81M |
Quarter End | |
---|---|
USD ($) | |
Total Assets | |
Total Liabilities | |
Total Equity |
Year End December 30 2022 | 2022 |
---|---|
USD ($) | |
Total Assets | 76.48M |
Total Liabilities | 524.6M |
Total Equity | -448.12M |
Market Cap | 5.59M |
Price to Earnings Ratio | -0.35 |
Price to Sales Ratio | 58.33 |
Price to Cash Ratio | 2.58 |
Price to Book Ratio | -0.19 |
Dividend Yield | - |
Shares Outstanding | 401.8M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.01 (69.88%) |
Company Name | Apollomics Inc |
Address |
989 e. hillsdale blvd foster city, california 94404 |
Website | https://www.apollomicsinc.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions